The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Open accessAbstract
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune system, which can affect multiple organs besides the lungs. Here, we propose that SARS-CoV-2 infection induces a process known as immunothrombosis, in which activated neutrophils and monocytes interact with platelets and the coagulation cascade, leading to intravascular clot formation in small and larger vessels. Microthrombotic complications may contribute to acute respiratory distress syndrome (ARDS) and other organ dysfunctions. Therapeutic strategies aimed at reducing immunothrombosis may therefore be useful. Several antithrombotic and immunomodulating drugs have been proposed as candidates to treat patients with SARS-CoV-2 infection. The growing understanding of SARS-CoV-2 infection pathogenesis and how it contributes to critical illness and its complications may help to improve risk stratification and develop targeted therapies to reduce the acute and long-term consequences of this disease. Here, the authors propose that SARS-CoV-2 induces a prothrombotic state, with dysregulated immunothrombosis in lung microvessels and endothelial injury, which drive the clinical manifestations of severe COVID-19. They discuss potential antithrombotic and immunomodulating drugs that are being considered in the treatment of patients with COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Tang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14817 · Cited by 3,559
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,885
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Extracellular DNA traps promote thrombosis
Fuchs, T. A., Brill, A., Duerschmied, D., Schatzberg, D., Monestier, M., Myers, D. D., Wrobleski, S. K., Wakefield, T. W., Hartwig, J. H., & Wagner, D. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005743107 · Cited by 2,492
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study
Wichmann, D., Sperhake, J.-P., Lütgehetmann, M., Steurer, S., Edler, C., Heinemann, A., Heinrich, F., Mushumba, H., Kniep, I., Schröder, A. S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2003 · Cited by 2,274
Endothelial Dysfunction: A Marker of Atherosclerotic Risk
Bonetti, P. O., Lerman, L. O., & Lerman, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000051384.43104.fc · Cited by 2,200
Magro, C., Mulvey, J. J., Berlin, D., Nuovo, G., Salvatore, S., Harp, J., Baxter-Stoltzfus, A., & Laurence, J. (2020) · Translational Research · doi:10.1016/j.trsl.2020.04.007 · Cited by 2,183
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., Kucher, N., Studt, J.-D., Sacco, C., Bertuzzi, A., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.024 · Cited by 2,054
Thrombosis as an intravascular effector of innate immunity
Engelmann, B., & Massberg, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3345 · Cited by 1,989
Self-citationHenry, B. M., de Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0369 · Cited by 1,964
COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Gattinoni, L., Chiumello, D., Caironi, P., Busana, M., Romitti, F., Brazzi, L., & Camporota, L. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06033-2 · Cited by 1,852
von Brühl, M.-L., Stark, K., Steinhart, A., Chandraratne, S., Konrad, I., Lorenz, M., Khandoga, A., Tirniceriu, A., Coletti, R., Köllnberger, M., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112322 · Cited by 1,823
Self-citationCOVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
Siddiqi, H. K., & Mehra, M. R. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.012 · Cited by 1,701
McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654
Neutrophil extracellular traps in COVID-19
Zuo, Y., Yalavarthi, S., Shi, H., Gockman, K., Zuo, M., Madison, J. A., Blair, C. N., Weber, A., Barnes, B. J., Egeblad, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138999 · Cited by 1,582
Fox, S. E., Akmatbekov, A., Harbert, J. L., Li, G., Quincy Brown, J., & Vander Heide, R. S. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30243-5 · Cited by 1,526
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200652 · Cited by 1,486
Middleton, E. A., He, X.-Y., Denorme, F., Campbell, R. A., Ng, D., Salvatore, S. P., Mostyka, M., Baxter-Stoltzfus, A., Borczuk, A. C., Loda, M., et al. (2020) · Blood · doi:10.1182/blood.2020007008 · Cited by 1,460
Berlin, D. A., Gulick, R. M., & Martinez, F. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmcp2009575 · Cited by 1,439
Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S.-Y. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.010 · Cited by 1,414
COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome
Gattinoni, L., Coppola, S., Cressoni, M., Busana, M., Rossi, S., & Chiumello, D. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0817le · Cited by 1,396
Carsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,396
COVID‐19 diagnosis and management: a comprehensive review
Pascarella, G., Strumia, A., Piliego, C., Bruno, F., Del Buono, R., Costa, F., Scarlata, S., & Agrò, F. E. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13091 · Cited by 1,369
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
Panigada, M., Bottino, N., Tagliabue, P., Grasselli, G., Novembrino, C., Chantarangkul, V., Pesenti, A., Peyvandi, F., & Tripodi, A. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14850 · Cited by 1,315
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases
Massberg, S., Grahl, L., von Bruehl, M.-L., Manukyan, D., Pfeiler, S., Goosmann, C., Brinkmann, V., Lorenz, M., Bidzhekov, K., Khandagale, A. B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2184 · Cited by 1,206
Self-citationGoshua, G., Pine, A. B., Meizlish, M. L., Chang, C.-H., Zhang, H., Bahel, P., Baluha, A., Bar, N., Bona, R. D., Burns, A. J., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30216-7 · Cited by 1,110
Management of COVID-19 Respiratory Distress
Marini, J. J., & Gattinoni, L. (2020) · JAMA · doi:10.1001/jama.2020.6825 · Cited by 1,100
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’
Lavezzo, E., Franchin, E., Ciavarella, C., Cuomo-Dannenburg, G., Barzon, L., Del Vecchio, C., Rossi, L., Manganelli, R., Loregian, A., Navarin, N., et al. (2020) · Nature · doi:10.1038/s41586-020-2488-1 · Cited by 1,087
Lung pathology of fatal severe acute respiratory syndrome
Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076
COVID-19: the vasculature unleashed
Teuwen, L.-A., Geldhof, V., Pasut, A., & Carmeliet, P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0343-0 · Cited by 1,008
The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome
Ranucci, M., Ballotta, A., Di Dedda, U., Baryshnikova, E., Dei Poli, M., Resta, M., Falco, M., Albano, G., & Menicanti, L. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14854 · Cited by 965
Platelet gene expression and function in patients with COVID-19
Manne, B. K., Denorme, F., Middleton, E. A., Portier, I., Rowley, J. W., Stubben, C., Petrey, A. C., Tolley, N. D., Guo, L., Cody, M., et al. (2020) · Blood · doi:10.1182/blood.2020007214 · Cited by 946
SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology
Veras, F. P., Pontelli, M. C., Silva, C. M., Toller-Kawahisa, J. E., de Lima, M., Nascimento, D. C., Schneider, A. H., Caetité, D., Tavares, L. A., Paiva, I. M., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201129 · Cited by 933
Paranjpe, I., Fuster, V., Lala, A., Russak, A. J., Glicksberg, B. S., Levin, M. A., Charney, A. W., Narula, J., Fayad, Z. A., Bagiella, E., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.001 · Cited by 920
Thrombosis: tangled up in NETs
Martinod, K., & Wagner, D. D. (2014) · Blood · doi:10.1182/blood-2013-10-463646 · Cited by 866
Self-citationLeisman, D. E., Ronner, L., Pinotti, R., Taylor, M. D., Sinha, P., Calfee, C. S., Hirayama, A. V., Mastroiani, F., Turtle, C. J., Harhay, M. O., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30404-5 · Cited by 855
Levi, M., & van der Poll, T. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2016.11.007 · Cited by 846
Self-citationRodrigues, T. S., de Sá, K. S. G., Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., Gonçalves, A. V., Perucello, D. B., Andrade, W. A., Castro, R., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201707 · Cited by 839
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
McGonagle, D., O'Donnell, J. S., Sharif, K., Emery, P., & Bridgewood, C. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30121-1 · Cited by 824
Bradley, B. T., Maioli, H., Johnston, R., Chaudhry, I., Fink, S. L., Xu, H., Najafian, B., Deutsch, G., Lacy, J. M., Williams, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31305-2 · Cited by 822
Skendros, P., Mitsios, A., Chrysanthopoulou, A., Mastellos, D. C., Metallidis, S., Rafailidis, P., Ntinopoulou, M., Sertaridou, E., Tsironidou, V., Tsigalou, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141374 · Cited by 786
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
Ding, Y., Wang, H., Shen, H., Li, Z., Geng, J., Han, H., Cai, J., Li, X., Kang, W., Weng, D., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1440 · Cited by 765
Hottz, E. D., Azevedo-Quintanilha, I. G., Palhinha, L., Teixeira, L., Barreto, E. A., Pão, C. R. R., Righy, C., Franco, S., Souza, T. M. L., Kurtz, P., et al. (2020) · Blood · doi:10.1182/blood.2020007252 · Cited by 751
Buchanan, J. T., Simpson, A. J., Aziz, R. K., Liu, G. Y., Kristian, S. A., Kotb, M., Feramisco, J., & Nizet, V. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.039 · Cited by 682
COVID-19 pneumonia: ARDS or not?
Gattinoni, L., Chiumello, D., & Rossi, S. (2020) · Critical Care · doi:10.1186/s13054-020-02880-z · Cited by 672
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
Zuo, Y., Estes, S. K., Ali, R. A., Gandhi, A. A., Yalavarthi, S., Shi, H., Sule, G., Gockman, K., Madison, J. A., Zuo, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3876 · Cited by 660
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
Zhang, S., Liu, Y., Wang, X., Yang, L., Li, H., Wang, Y., Liu, M., Zhao, X., Xie, Y., Yang, Y., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00954-7 · Cited by 657
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Gralinski, L. E., Sheahan, T. P., Morrison, T. E., Menachery, V. D., Jensen, K., Leist, S. R., Whitmore, A., Heise, M. T., & Baric, R. S. (2018) · mBio · doi:10.1128/mbio.01753-18 · Cited by 655
Complement and coagulation: strangers or partners in crime?
Markiewski, M. M., Nilsson, B., Nilsson Ekdahl, K., Mollnes, T. E., & Lambris, J. D. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.02.006 · Cited by 645
Wang, Y., Liu, S., Liu, H., Li, W., Lin, F., Jiang, L., Li, X., Xu, P., Zhang, L., Zhao, L., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.002 · Cited by 626
Jackson, S. P., Darbousset, R., & Schoenwaelder, S. M. (2019) · Blood · doi:10.1182/blood-2018-11-882993 · Cited by 616
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Renia, L., & Remuzzi, G. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 607
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications
McFadyen, J. D., Stevens, H., & Peter, K. (2020) · Circulation Research · doi:10.1161/circresaha.120.317447 · Cited by 592
An Endonuclease Allows Streptococcus pneumoniae to Escape from Neutrophil Extracellular Traps
Beiter, K., Wartha, F., Albiger, B., Normark, S., Zychlinsky, A., & Henriques-Normark, B. (2006) · Current Biology · doi:10.1016/j.cub.2006.01.056 · Cited by 587
Postmortem Examination of Patients With COVID-19
Schaller, T., Hirschbühl, K., Burkhardt, K., Braun, G., Trepel, M., Märkl, B., & Claus, R. (2020) · JAMA · doi:10.1001/jama.2020.8907 · Cited by 557
Nicolai, L., Leunig, A., Brambs, S., Kaiser, R., Weinberger, T., Weigand, M., Muenchhoff, M., Hellmuth, J. C., Ledderose, S., Schulz, H., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048488 · Cited by 557
Self-citationWang, J., Hajizadeh, N., Moore, E. E., McIntyre, R. C., Moore, P. K., Veress, L. A., Yaffe, M. B., Moore, H. B., & Barrett, C. D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14828 · Cited by 536
Coagulopathy of Coronavirus Disease 2019
Iba, T., Levy, J. H., Levi, M., Connors, J. M., & Thachil, J. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004458 · Cited by 534
Self-citationSchurink, B., Roos, E., Radonic, T., Barbe, E., Bouman, C. S. C., de Boer, H. H., de Bree, G. J., Bulle, E. B., Aronica, E. M., Florquin, S., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30144-0 · Cited by 512
Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19
Zaid, Y., Puhm, F., Allaeys, I., Naya, A., Oudghiri, M., Khalki, L., Limami, Y., Zaid, N., Sadki, K., Ben El Haj, R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317703 · Cited by 496
NETosis, complement, and coagulation: a triangular relationship
de Bont, C. M., Boelens, W. C., & Pruijn, G. J. M. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-018-0024-0 · Cited by 492
Ritis, K., Doumas, M., Mastellos, D., Micheli, A., Giaglis, S., Magotti, P., Rafail, S., Kartalis, G., Sideras, P., & Lambris, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4794 · Cited by 489
Complement as a target in COVID-19?
Risitano, A. M., Mastellos, D. C., Huber-Lang, M., Yancopoulou, D., Garlanda, C., Ciceri, F., & Lambris, J. D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0320-7 · Cited by 484
Ciceri, F., Beretta, L., Scandroglio, A. M., Colombo, S., Landoni, G., Ruggeri, A., Peccatori, J., D’Angelo, A., De Cobelli, F., Rovere-Querini, P., et al. (2020) · Critical Care and Resuscitation · doi:10.51893/2020.2.pov2 · Cited by 483
Self-citationWolach, O., Sellar, R. S., Martinod, K., Cherpokova, D., McConkey, M., Chappell, R. J., Silver, A. J., Adams, D., Castellano, C. A., Schneider, R. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8292 · Cited by 481
Self-citationHistopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
Zhang, H., Zhou, P., Wei, Y., Yue, H., Wang, Y., Hu, M., Zhang, S., Cao, T., Yang, C., Li, M., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0533 · Cited by 474
Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury
Lefrançais, E., Mallavia, B., Zhuo, H., Calfee, C. S., & Looney, M. R. (2018) · JCI Insight · doi:10.1172/jci.insight.98178 · Cited by 467
Barnes, G. D., Burnett, A., Allen, A., Blumenstein, M., Clark, N. P., Cuker, A., Dager, W. E., Deitelzweig, S. B., Ellsworth, S., Garcia, D., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02138-z · Cited by 467
Cao, Y., Wei, J., Zou, L., Jiang, T., Wang, G., Chen, L., Huang, L., Meng, F., Huang, L., Wang, N., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.019 · Cited by 456
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Nadkarni, G. N., Lala, A., Bagiella, E., Chang, H. L., Moreno, P. R., Pujadas, E., Arvind, V., Bose, S., Charney, A. W., Chen, M. D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.041 · Cited by 452
Vascular occlusion by neutrophil extracellular traps in COVID-19
Leppkes, M., Knopf, J., Naschberger, E., Lindemann, A., Singh, J., Herrmann, I., Stürzl, M., Staats, L., Mahajan, A., Schauer, C., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102925 · Cited by 446
Severe COVID-19 infection associated with endothelial activation
Escher, R., Breakey, N., & Lämmle, B. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.014 · Cited by 441
The coagulopathy, endotheliopathy, and vasculitis of COVID-19
Iba, T., Connors, J. M., & Levy, J. H. (2020) · Inflammation Research · doi:10.1007/s00011-020-01401-6 · Cited by 429
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
Gu, S. X., Tyagi, T., Jain, K., Gu, V. W., Lee, S. H., Hwa, J. M., Kwan, J. M., Krause, D. S., Lee, A. I., Halene, S., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00469-1 · Cited by 418
Wang, C., Xie, J., Zhao, L., Fei, X., Zhang, H., Tan, Y., Nie, X., Zhou, L., Liu, Z., Ren, Y., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102833 · Cited by 412
AMMOLLO, C. T., SEMERARO, F., XU, J., ESMON, N. L., & ESMON, C. T. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04422.x · Cited by 392
Yalavarthi, S., Gould, T. J., Rao, A. N., Mazza, L. F., Morris, A. E., Núñez‐Álvarez, C., Hernández‐Ramírez, D., Bockenstedt, P. L., Liaw, P. C., Cabral, A. R., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39247 · Cited by 391
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
Wang, T., Chen, R., Liu, C., Liang, W., Guan, W., Tang, R., Tang, C., Zhang, N., Zhong, N., & Li, S. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30109-5 · Cited by 376
The complement system in COVID-19: friend and foe?
Java, A., Apicelli, A. J., Liszewski, M. K., Coler-Reilly, A., Atkinson, J. P., Kim, A. H. J., & Kulkarni, H. S. (2020) · JCI Insight · doi:10.1172/jci.insight.140711 · Cited by 376
Zhang, G., Han, J., Welch, E. J., Ye, R. D., Voyno-Yasenetskaya, T. A., Malik, A. B., Du, X., & Li, Z. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802884 · Cited by 363
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
Ramlall, V., Thangaraj, P. M., Meydan, C., Foox, J., Butler, D., Kim, J., May, B., De Freitas, J. K., Glicksberg, B. S., Mason, C. E., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1021-2 · Cited by 351
Radermecker, C., Detrembleur, N., Guiot, J., Cavalier, E., Henket, M., d’Emal, C., Vanwinge, C., Cataldo, D., Oury, C., Delvenne, P., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201012 · Cited by 349
Neutrophil elastase inhibition in acute lung injury: Results of the STRIVE study
Zeiher, B. G., Artigas, A., Vincent, J.-L., Dmitrienko, A., Jackson, K., Thompson, B. T., & Bernard, G. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000133332.48386.85 · Cited by 347
Yamamoto, M., Matsuyama, S., Li, X., Takeda, M., Kawaguchi, Y., Inoue, J.-I., & Matsuda, Z. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01043-16 · Cited by 340
Larsson, M., Rayzman, V., Nolte, M. W., Nickel, K. F., Björkqvist, J., Jämsä, A., Hardy, M. P., Fries, M., Schmidbauer, S., Hedenqvist, P., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006804 · Cited by 338
Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions
Kox, M., Waalders, N. J. B., Kooistra, E. J., Gerretsen, J., & Pickkers, P. (2020) · JAMA · doi:10.1001/jama.2020.17052 · Cited by 333
Diurno, F., Numis, F. G., Porta, G., Cirillo, F., Maddaluno, S., Ragozzino, A., Negri, P. D., Gennaro, C. D., Pagano, A., Allegorico, E., et al. (2020) · PubMed · doi:10.26355/eurrev_202004_20875 · Cited by 326
Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity
Cheng, A. G., McAdow, M., Kim, H. K., Bae, T., Missiakas, D. M., & Schneewind, O. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001036 · Cited by 324
Reinhardt, C., von Brühl, M.-L., Manukyan, D., Grahl, L., Lorenz, M., Altmann, B., Dlugai, S., Hess, S., Konrad, I., Orschiedt, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32376 · Cited by 323
Self-citationMechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
Gralinski, L. E., Bankhead, A., Jeng, S., Menachery, V. D., Proll, S., Belisle, S. E., Matzke, M., Webb-Robertson, B.-J. M., Luna, M. L., Shukla, A. K., et al. (2013) · mBio · doi:10.1128/mbio.00271-13 · Cited by 310
Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice
Thomas, G. M., Carbo, C., Curtis, B. R., Martinod, K., Mazo, I. B., Schatzberg, D., Cifuni, S. M., Fuchs, T. A., von Andrian, U. H., Hartwig, J. H., et al. (2012) · Blood · doi:10.1182/blood-2012-01-405183 · Cited by 307
Self-citationHuang, B., Chen, Z., Geng, L., Wang, J., Liang, H., Cao, Y., Chen, H., Huang, W., Su, M., Wang, H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.027 · Cited by 307
Review: Viral infections and mechanisms of thrombosis and bleeding
Goeijenbier, M., van Wissen, M., van de Weg, C., Jong, E., Gerdes, V. E. A., Meijers, J. C. M., Brandjes, D. P. M., & van Gorp, E. C. M. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23354 · Cited by 299
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
Mastaglio, S., Ruggeri, A., Risitano, A. M., Angelillo, P., Yancopoulou, D., Mastellos, D. C., Huber-Lang, M., Piemontese, S., Assanelli, A., Garlanda, C., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108450 · Cited by 283
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
Liu, X., Li, Z., Liu, S., Sun, J., Chen, Z., Jiang, M., Zhang, Q., Wei, Y., Wang, X., Huang, Y.-Y., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.008 · Cited by 274
Whyte, C. S., Morrow, G. B., Mitchell, J. L., Chowdary, P., & Mutch, N. J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14872 · Cited by 273
C5a Induces Tissue Factor Activity on Endothelial Cells
Ikeda, K., Nagasawa, K., Horiuchi, T., Tsuru, T., Nishizaka, H., & Niho, Y. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655974 · Cited by 272
Mastellos, D. C., Pires da Silva, B. G. P., Fonseca, B. A. L., Fonseca, N. P., Auxiliadora-Martins, M., Mastaglio, S., Ruggeri, A., Sironi, M., Radermacher, P., Chrysanthopoulou, A., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108598 · Cited by 255
Papayannopoulos, V., Staab, D., & Zychlinsky, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028526 · Cited by 251
Intravascular immunity: the host–pathogen encounter in blood vessels
Hickey, M. J., & Kubes, P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2532 · Cited by 251
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
La Rosée, F., Bremer, H. C., Gehrke, I., Kehr, A., Hochhaus, A., Birndt, S., Fellhauer, M., Henkes, M., Kumle, B., Russo, S. G., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0891-0 · Cited by 231
Guo, L., & Rondina, M. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02204 · Cited by 224
Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis
MA, A. C., & KUBES, P. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02865.x · Cited by 217
Kambas, K., Mitroulis, I., Apostolidou, E., Girod, A., Chrysanthopoulou, A., Pneumatikos, I., Skendros, P., Kourtzelis, I., Koffa, M., Kotsianidis, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045427 · Cited by 207
Stebbing, J., Sánchez Nievas, G., Falcone, M., Youhanna, S., Richardson, P., Ottaviani, S., Shen, J. X., Sommerauer, C., Tiseo, G., Ghiadoni, L., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe4724 · Cited by 207
Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
Ali, R. A., Gandhi, A. A., Meng, H., Yalavarthi, S., Vreede, A. P., Estes, S. K., Palmer, O. R., Bockenstedt, P. L., Pinsky, D. J., Greve, J. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09801-x · Cited by 199
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
Alon, R., Sportiello, M., Kozlovski, S., Kumar, A., Reilly, E. C., Zarbock, A., Garbi, N., & Topham, D. J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00470-2 · Cited by 197
COVID-19 vasculitis and novel vasculitis mimics
McGonagle, D., Bridgewood, C., Ramanan, A. V., Meaney, J. F. M., & Watad, A. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30420-3 · Cited by 192
Pathogenetic mechanisms of severe acute respiratory syndrome
Guo, Y., Korteweg, C., McNutt, M. A., & Gu, J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.01.022 · Cited by 188
Yan, S.-F., Mackman, N., Kisiel, W., Stern, D. M., & Pinsky, D. J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2029 · Cited by 185
Annane, D., Heming, N., Grimaldi-Bensouda, L., Frémeaux-Bacchi, V., Vigan, M., Roux, A.-L., Marchal, A., Michelon, H., Rottman, M., & Moine, P. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100590 · Cited by 177
Fibrinolysis and host response in bacterial infections
Bergmann, S., & Hammerschmidt, S. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-02-0117 · Cited by 176
The association between treatment with heparin and survival in patients with Covid-19
Ayerbe, L., Risco, C., & Ayis, S. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02162-z · Cited by 176
cAMP and Epac in the regulation of tissue fibrosis
Insel, P. A., Murray, F., Yokoyama, U., Romano, S., Yun, H., Brown, L., Snead, A., Lu, D., & Aroonsakool, N. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01847.x · Cited by 175
Neutrophil accumulation and NET release contribute to thrombosis in HIT
Gollomp, K., Kim, M., Johnston, I., Hayes, V., Welsh, J., Arepally, G. M., Kahn, M., Lambert, M. P., Cuker, A., Cines, D. B., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99445 · Cited by 171
The Pathophysiological Role of Neutrophil Extracellular Traps in Inflammatory Diseases
Bonaventura, A., Liberale, L., Carbone, F., Vecchié, A., Díaz-Cañestro, C., Camici, G. G., Montecucco, F., & Dallegri, F. (2018) · Thrombosis and Haemostasis · doi:10.1160/th17-09-0630 · Cited by 167
Self-citationSemple, J. W., Aslam, R., Kim, M. S., Speck, E. R., & Freedman, J. J. (2007) · Blood · doi:10.1182/blood-2006-12-062695 · Cited by 162
Neonatal NET-inhibitory factor and related peptides inhibit neutrophil extracellular trap formation
Yost, C. C., Schwertz, H., Cody, M. J., Wallace, J. A., Campbell, R. A., Vieira‐de‐Abreu, A., de Araujo, C. V., Schubert, S., Harris, E. S., Rowley, J. W., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83873 · Cited by 161
Bösmüller, H., Traxler, S., Bitzer, M., Häberle, H., Raiser, W., Nann, D., Frauenfeld, L., Vogelsberg, A., Klingel, K., & Fend, F. (2020) · Virchows Archiv · doi:10.1007/s00428-020-02881-x · Cited by 159
Quartuccio, L., Sonaglia, A., McGonagle, D., Fabris, M., Peghin, M., Pecori, D., Monte, A. D., Bove, T., Curcio, F., Bassi, F., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104444 · Cited by 156
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
Bonaventura, A., Vecchié, A., Wang, T. S., Lee, E., Cremer, P. C., Carey, B. C., Rajendram, P., Hudock, K. M., Korbee, L. L., Tassell, B. W. V., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01625 · Cited by 141
Self-citationClinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan
Adachi, T., Chong, J., Nakajima, N., Sano, M., Yamazaki, J., Miyamoto, I., Nishioka, H., Akita, H., Sato, Y., Kataoka, M., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2609.201353 · Cited by 138
Peerschke, E. I. B., Reid, K. B. M., & Ghebrehiwet, B. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.2.579 · Cited by 137
Schwameis, M., Schoergenhofer, C., Assinger, A., Steiner, M. M., & Jilma, B. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-09-0731 · Cited by 137
IL‐18 and infections: Is there a role for targeted therapies?
Vecchié, A., Bonaventura, A., Toldo, S. A., Dagna, L., Dinarello, C. A., & Abbate, A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30008 · Cited by 136
Self-citationInflammasome formation in the lungs of patients with fatal COVID-19
Toldo, S., Bussani, R., Nuzzi, V., Bonaventura, A., Mauro, A. G., Cannatà, A., Pillappa, R., Sinagra, G., Nana-Sinkam, P., Sime, P., et al. (2021) · Inflammation Research · doi:10.1007/s00011-020-01413-2 · Cited by 132
Self-citationProposal of the Definition for COVID-19-Associated Coagulopathy
Iba, T., Warkentin, T. E., Thachil, J. V., Levi, M. M., & Levy, J. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020191 · Cited by 132
Self-citationCirculating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19
Guervilly, C., Burtey, S., Sabatier, F., Cauchois, R., Lano, G., Abdili, E., Daviet, F., Arnaud, L., Brunet, P., Hraiech, S., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa528 · Cited by 129
Kawasaki, Y., & Aikawa, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s65066 · Cited by 122
Complementopathies and precision medicine
Gavriilaki, E., & Brodsky, R. A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136094 · Cited by 115
Guggenberger, C., Wolz, C., Morrissey, J. A., & Heesemann, J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002434 · Cited by 114
Tagami, T., Tosa, R., Omura, M., Fukushima, H., Kaneko, T., Endo, T., Rinka, H., Murai, A., Yamaguchi, J., Yoshikawa, K., et al. (2014) · Journal of Intensive Care · doi:10.1186/s40560-014-0067-y · Cited by 109
Hepatic consequences of COVID-19 infection. Lapping or biting?
Portincasa, P., Krawczyk, M. J., Machill, A., Lammert, F., & Ciaula, A. D. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.05.035 · Cited by 106
Chen, L., & Hao, G. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa093 · Cited by 104
Potential of heparin and nafamostat combination therapy for COVID‐19
Asakura, H., & Ogawa, H. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14858 · Cited by 102
Weber, A. G., Chau, A. S., Egeblad, M., Barnes, B. J., & Janowitz, T. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00215-w · Cited by 102
Chrysanthopoulou, A., Kambas, K., Stakos, D., Mitroulis, I., Mitsios, A., Vidali, V. P., Angelidou, I., Bochenek, M. L., Arelaki, S., Αραμπατζιόγλου, Α., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4935 · Cited by 99
Direct oral anticoagulant use and risk of severe COVID‐19
Flam, B., Wintzell, V., Ludvigsson, J. F., Mårtensson, J., & Pasternak, B. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13205 · Cited by 97
Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant)
Pinto, C. M., García‐Carrasco, M., & Cervera, R. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0773-x · Cited by 95
Rebetz, J., Semple, J. W., & Kapur, R. (2018) · Transfusion Medicine and Hemotherapy · doi:10.1159/000492950 · Cited by 92
Bendib, I., de Chaisemartin, L., Granger, V., Schlemmer, F., Maître, B., Hüe, S., Surénaud, M., Beldi‐Ferchiou, A., Carteaux, G., Razazi, K., et al. (2019) · Anesthesiology · doi:10.1097/aln.0000000000002619 · Cited by 91
Lv, X., Wen, T., Song, J., Xie, D., Wu, L., Jiang, X., Jiang, P., & Wen, Z. (2017) · Respiratory Research · doi:10.1186/s12931-017-0651-5 · Cited by 78
NETopathies? Unraveling the Dark Side of Old Diseases through Neutrophils
Mitsios, A., Αραμπατζιόγλου, Α., Arelaki, S., Mitroulis, I., & Ritis, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00678 · Cited by 73
Levi, M. M. (2016) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0035-1570080 · Cited by 72
Self-citationRossi, R., Coppi, F., Talarico, M., & Boriani, G. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.06.006 · Cited by 71
Gazzaruso, C., Paolozzi, E., Valenti, C., Brocchetta, M., Naldani, D., Grignani, C., Salvucci, F., Marino, F., Coppola, A., & Gallotti, P. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.07.040 · Cited by 69
Platelets in Host Defense: Experimental and Clinical Insights
Nicolai, L., Gaertner, F. C., & Maßberg, S. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.08.004 · Cited by 66
Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
Liu, C., Ma, Y., Su, Z., Zhao, R., Zhao, X., Nie, H., Xu, P., Zhu, L., Zhang, M., Li, X., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01898 · Cited by 63
Dipyridamole Reversibly Inhibits Mengovirus RNA Replication
Fata-Hartley, C. L., & Palmenberg, A. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11062-11070.2005 · Cited by 59
Thrombosis and coagulopathy in COVID‐19: An illustrated review
Levi, M. M., & Hunt, B. J. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12400 · Cited by 59
Self-citationZou, Y., Chen, X., Xiao, J., Zhou, D. B., Lu, X. X., Li, W., Xie, B., Kuang, X., & Chen, Q. (2018) · Oncotarget · doi:10.18632/oncotarget.24022 · Cited by 57
Myeloperoxidase Directs Properdin-Mediated Complement Activation
O'Flynn, J., Dixon, K. O., Krol, M. C. F., Daha, M. R., & van Kooten, C. (2013) · Journal of Innate Immunity · doi:10.1159/000356980 · Cited by 54
Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
Okur, H. K., Yalçın, K., Taştan, C., Demir, S., Yurtsever, B., Karakuş, G. S., Kançağı, D. D., Abanuz, S., Seyis, U., Zengin, R., et al. (2020) · New Microbes and New Infections · doi:10.1016/j.nmni.2020.100756 · Cited by 53
Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019
Buckley, L. F., Wohlford, G. F., Ting, C., Alahmed, A. A., Tassell, B. W. V., Abbate, A., Devlin, J. W., & Libby, P. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000178 · Cited by 49
Self-citationCavalli, G., Farina, N., Campochiaro, C., Luca, G. D. D., Della‐Torre, E., Tomelleri, A., & Dagna, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598308 · Cited by 38
Self-citationKanthi, Y. M., Knight, J. S., Zuo, Y., & Pinsky, D. J. (2020) · JCI Insight · doi:10.1172/jci.insight.140971 · Cited by 37
Ticagrelor Exerts Immune-Modulatory Effect by Attenuating Neutrophil Extracellular Traps
Mitsios, A., Chrysanthopoulou, A., Αραμπατζιόγλου, Α., Angelidou, I., Vidali, V. P., Ritis, K., Skendros, P., & Stakos, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103625 · Cited by 35
Bonaventura, A., Montecucco, F., & Dallegri, F. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1227779 · Cited by 23
Self-citationMir, N. A., D’Amico, A., Dasher, J., Tolwani, A., & Valentine, V. G. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100731 · Cited by 16
Cited by
Lamers, M. M., & Haagmans, B. L. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00713-0 · Cited by 983
Inflammatory Mechanisms Contributing to Endothelial Dysfunction
Theofilis, P., Sagris, M., Oikonomou, E., Antonopoulos, A. S., Siasos, G., Tsioufis, C., & Tousoulis, D. (2021) · Biomedicines · doi:10.3390/biomedicines9070781 · Cited by 568
The cGAS–STING pathway drives type I IFN immunopathology in COVID-19
Domizio, J. D., Gulen, M. F., Saidoune, F., Thacker, V. V., Yatim, A., Sharma, K., Nass, T., Guenova, E., Schaller, M., Conrad, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04421-w · Cited by 538
Understanding COVID-19-associated coagulopathy
Conway, E. M., Mackman, N., Warren, R. Q., Wolberg, A. S., Mosnier, L. O., Campbell, R. A., Gralinski, L. E., Rondina, M. T., van de Veerdonk, F. L., Hoffmeister, K. M., et al. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00762-9 · Cited by 359
The role of platelets in immune-mediated inflammatory diseases
Scherlinger, M., Richez, C., Tsokos, G. C., Boilard, E., & Blanco, P. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00834-4 · Cited by 346
Metadata
- Authors
- Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Van Tassell, B. W., Dentali, F., Montecucco, F., Massberg, S., Levi, M., & Abbate, A.
- Venue
- Nature Reviews Immunology
- Published
- 2021-04-06
- Volume
- 21
- Issue
- 5
- Pages
- 319-329
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W3140915421
- Cited by
- 987
- References
- 175
- FWCI
- 25.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.